This result indicates that Btbd7 may contribute to cancer cell invasion and is consistent with the results in vivo that indicate its association with lymph node metastasis and patients’ poor clinical outcome. The gene discussed is BTBD7; the disease is metastatic malignant neoplasm in the lymph nodes.